INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 4 Jul · 18:11 IST

Ind-Swift Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories has submitted a compliance certificate for the quarter ended June 30, 2025, as required by SEBI rules. The certificate was issued by Alankit Assignments Ltd., the company's Registrar and Share Transfer Agent. It confirms that physical share certificates received from shareholders for converting into demat form have been verified, listed on the stock exchanges, mutilated, and cancelled, with the depository now recorded as the registered owner. This is a standard quarterly procedural filing with no business or financial details disclosed.

Likely market impact

This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or stock price. It simply reflects the normal process of shareholders moving from physical to demat holdings.